Gulf Coast Consortia Antimicrobial Resistance Cluster (GCC AMR)
A collaboration of leaders in antimicrobial resistance researchers from all of GCC institutions as well as additional TMC institutions (Baylor, Rice, TAMHSC Institute for Biosciences and Technology, University of Houston, UTHealth [with the newly created UTHealth Center for Antimicrobial Resistance and Microbial Genomics], MD Anderson, UTMB Galveston, and Methodist Research Institute) have recognized the strength and potential of working together to solve the global problem of antimicrobial resistance. To this end they have formed this GCC cluster in 2016.
The GCC AMR seeks to create a robust collaborative research environment within the GCC and surrounding institutions focused on antibiotic resistance in order to increase basic, translational and patient oriented research (POR). Since the problem of AMR encompasses a variety of fields and is inherently interdisciplinary, the focus on this important problem will stimulate and strengthen collaborations among basic and clinical researchers (including clinicians) from the GCC Texas Medical Center institutions.
AMR Leadership: Cesar Arias (Chair), UTHealth; Lynn Zechiedrich (Co-Chair), Baylor College of Medicine; Tim Palzkill, Baylor College of Medicine; Ashok Chopra, UTMB; Samuel Shelburne, MD Anderson Cancer Center; Julian Hurdle, TAMHSC IBT; Magnus Hook, TAMHSC IBT; Yousif Shamoo, Rice U.; Vincent Tam, U. of Houston; and Adriana Rosato, HMRI.
Mike Hogg Antimicrobial Resistance Research Seminar Series, 1st Quartely Stewardship Update, April 6
Trish M Perl, MD, MSc, Chief of Infectious Diseases and the Jay P Sanford professor in the Department of Medicine, Infectious Diseases at the University of Texas, Southwestern Medical Center in Dallas will first present “The Next Pandemic and Emerging Antimicrobial-Resistant Pathogens.” Following will be a real-time clinical stewardship update focused on clinical microbiology.